Nebicapone

硝苄卡朋

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameNebicapone
Drug Alias Namenebicapona奈比卡朋nebicaponumBIA-3202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatechol-O-methyl transferase inhibitors
TargetsCatechol-O-methyl transferase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugalSwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBial
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBial - Portela C Sa
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A